RedDress Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

RedDress General Information

Description

Developer of autologous healing solutions designed to treat chronic and non-healing wounds using a patient's own blood. The company's primary product, ActiGraftPro, creates an in vitro blood clot that facilitates the natural healing process, enabling healthcare providers to achieve superior healing rates for complex wounds while integrating seamlessly into existing clinical workflows.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 822 A1A North
  • Suite 310
  • Ponte Vedra Beach, FL 32082
  • United States
+1 (800)
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 822 A1A North
  • Suite 310
  • Ponte Vedra Beach, FL 32082
  • United States
+1 (800)

RedDress Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RedDress Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Jul-2024 Completed Generating Revenue
2. Later Stage VC (Series D) 15-May-2023 Completed Generating Revenue
1. Later Stage VC 01-May-2020 $16.5M $16.5M Completed Generating Revenue
To view RedDress’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RedDress Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of autologous healing solutions designed to treat chronic and non-healing wounds using a patient's own blood.
Therapeutic Devices
Ponte Vedra Beach, FL
36 As of 2025

Isafjordur, Iceland
 

Marietta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RedDress Competitors (5)

One of RedDress’s 5 competitors is Kerecis, a Formerly VC-backed company based in Isafjordur, Iceland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kerecis Formerly VC-backed Isafjordur, Iceland
Mimedx Group Corporation Marietta, GA
Organogenesis Holdings Pending Transaction (M&A) Canton, MA
3M Corporation Saint Paul, MN
Smith & Nephew (medical devices) Corporation
You’re viewing 5 of 5 competitors. Get the full list »

RedDress Patents

RedDress Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025243305-A1 Controlled drug delivery Pending 23-May-2024
WO-2025243291-A1 Method and kit for treating a wound Pending 19-May-2024
EP-4673188-A1 Method and kit for treating damaged connective tissue Pending 02-Mar-2023
US-20260224869-A1 Method and kit for treating damaged connective tissue Pending 02-Mar-2023
WO-2024180534-A1 Method and kit for treating damaged connective tissue Inactive 02-Mar-2023 A61B17/11
To view RedDress’s complete patent history, request access »

RedDress Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RedDress Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Katao Venture Partners Venture Capital Minority
Alpha (Israel) Venture Capital Minority
ATHOS Biopharma Venture Capital Minority
Boston Harbor Angels Angel Group Minority
To view RedDress’s complete investors history, request access »

RedDress FAQs

  • When was RedDress founded?

    RedDress was founded in 2009.

  • Where is RedDress headquartered?

    RedDress is headquartered in Ponte Vedra Beach, FL.

  • What is the size of RedDress?

    RedDress has 36 total employees.

  • What industry is RedDress in?

    RedDress’s primary industry is Therapeutic Devices.

  • Is RedDress a private or public company?

    RedDress is a Private company.

  • What is RedDress’s current revenue?

    The current revenue for RedDress is .

  • How much funding has RedDress raised over time?

    RedDress has raised $42.5M.

  • Who are RedDress’s investors?

    Katao Venture Partners, Alpha (Israel), ATHOS Biopharma, and Boston Harbor Angels have invested in RedDress.

  • Who are RedDress’s competitors?

    Kerecis, Mimedx Group, Organogenesis Holdings, 3M, and Smith & Nephew (medical devices) are competitors of RedDress.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process